RENX
NEUTRALRenalytix PLC Announces Change in Shareholding
The healthcare company has announced a change in its major shareholder's holdings.
Renalytix
8.35GBX
4.38%
Market Cap
27.66M
Volume
30.23k
18% of avg
P/E Ratio
-0.93
EPS (TTM)
-0.09
Beta
1.94
Day Range
8.35p - 8.50p
52 Week Range
6.50p8.35p30.00p
8.35p
Upcoming Events
RENX
NEUTRALRenalytix Plc Announces Holding(s) in Company
The healthcare company has received a notification of a change in shareholding.
RENX
NEUTRALRenalytix PLC: UBS Group AG Reduces Stake Below 5%
The healthcare technology company reports a change in shareholding, with a major investor reducing its stake below the 5% reporting threshold.
RENX
NEUTRALRenalytix Plc Announces Holding(s) in Company
The healthcare company has announced a change in its shareholder structure.
RENX
NEUTRALRenalytix Provides Update on KidneyIntelX Data
The healthcare company has released new data on the impact of its KidneyIntelX diagnostic tool, highlighting its ability to drive changes in care for patients.
RENX
GOODRenalytix Delivers 20% Quarterly Revenue Growth, Reaches Key Testing Milestone
The healthcare technology company reports 20% quarterly revenue growth and reaches a key milestone of 1,000 billable tests processed in a quarter.
RENX
NEUTRALRenalytix PLC: Holding(s) in Company
The healthcare technology company has received a notification of a change in shareholding.
RENX
NEUTRALRenalytix Plc Announces Holding(s) in Company
The healthcare company has received a notification of a change in shareholding.
RENX
NEUTRALRenalytix Plc Announces Change in Shareholding
The healthcare technology company has announced a change in its major shareholder's holdings.
RENX
NEUTRALRenalytix Plc Announces Director Dealings
The healthcare company has announced changes to its major shareholders.